- Latest week
- 10 Jul 2026
- Close
- 6.250000
- Fair value
- 4.453333
- Next-week expectancy
- Positive 60.66%
TTX Chart Pack
Tetratherix Limited
Chart Summary
Over the latest 12 completed weeks ending 2026-07-10, TTX rose 32.14%, moving from 4.73 to 6.25. The latest weekly close is above the Trend Line and above Fair Value. Trend Signal is active on the latest week and was active in 12 of the last 12 weeks. Relative Strength is 39.33 and has remained broadly mixed across the 12-week window. Market Dynamics is 0.80 on the latest week. Next-week expectancy is positive at 60.66% based on similar historical setup states.
Key Points
- Week Ending
- 10 Jul 2026
- Latest Close
- 6.25
- 12-Week Change
- 32.14%
- Trend Signal
- Active
- Next-Week Expectancy
- Positive 60.66%
- Signal Weeks
- 12 of 12
- Vs Trend Line
- Above
- Vs Fair Value
- Above
- Relative Strength
- 39.33
- Market Dynamics
- 0.80
Weekly Price
Price Action
Smart Money
Market Dynamics
Price Cycle
Next-State Map
SMI
Chart Summary
Key Points
- Week Ending
- 10 Jul 2026
- Latest Close
- 6.25
- 12-Week Change
- 32.14%
- Trend Signal
- Active
- Next-Week Expectancy
- Positive 60.66%
- Signal Weeks
- 12 of 12
- Vs Trend Line
- Above
- Vs Fair Value
- Above
- Relative Strength
- 39.33
- Market Dynamics
- 0.80
Over the latest 12 completed weeks ending 2026-07-10, TTX rose 32.14%, moving from 4.73 to 6.25. The latest weekly close is above the Trend Line and above Fair Value. Trend Signal is active on the latest week and was active in 12 of the last 12 weeks. Relative Strength is 39.33 and has remained broadly mixed across the 12-week window. Market Dynamics is 0.80 on the latest week. Next-week expectancy is positive at 60.66% based on similar historical setup states.
Industry Peers
Australia equities in Biotechnology
| Stock | Exchange | Week | Open | High | Low | Close | Change |
|---|---|---|---|---|---|---|---|
| VBS Vectus Biosystems Limited | ASX | 10 Jul 2026 | 0.12 | 0.16 | 0.12 | 0.16 | 33.33% |
| ACW Actinogen Medical Limited | ASX | 10 Jul 2026 | 0.04 | 0.04 | 0.04 | 0.04 | 22.22% |
| ILA Island Pharmaceuticals Limited | ASX | 10 Jul 2026 | 0.38 | 0.55 | 0.38 | 0.45 | 20.00% |
| IMC Immuron Limited | ASX | 10 Jul 2026 | 0.04 | 0.04 | 0.04 | 0.04 | 10.26% |
| MSB Mesoblast Limited | ASX | 10 Jul 2026 | 2.04 | 2.30 | 1.97 | 2.24 | 9.80% |
| ENP Entropy Neurodynamics Limited | ASX | 10 Jul 2026 | 0.03 | 0.04 | 0.03 | 0.04 | 9.38% |
| BOT Botanix Pharmaceuticals Limited | ASX | 10 Jul 2026 | 0.02 | 0.03 | 0.02 | 0.02 | 9.09% |
| CU6 Clarity Pharmaceuticals Ltd | ASX | 10 Jul 2026 | 2.21 | 2.65 | 2.20 | 2.41 | 9.05% |
| PTX Prescient Therapeutics Limited | ASX | 10 Jul 2026 | 0.07 | 0.08 | 0.07 | 0.07 | 2.86% |
| PYC PYC Therapeutics Limited | ASX | 10 Jul 2026 | 1.53 | 1.60 | 1.49 | 1.56 | 1.63% |
| CSL CSL Limited | ASX | 10 Jul 2026 | 121.85 | 126.98 | 120.75 | 122.89 | 0.85% |
| ANR Anatara Lifesciences Ltd | ASX | 10 Jul 2026 | 0.01 | 0.01 | 0.01 | 0.01 | 0.00% |
| BIT Biotron Limited | ASX | 10 Jul 2026 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00% |
| BTC BTC Health Limited | ASX | 10 Jul 2026 | 0.06 | 0.06 | 0.06 | 0.06 | 0.00% |
| IXC Invex Therapeutics Ltd | ASX | 10 Jul 2026 | 0.11 | 0.11 | 0.11 | 0.11 | 0.00% |
| NTI Neurotech International Limited | ASX | 10 Jul 2026 | 0.02 | 0.02 | 0.02 | 0.02 | 0.00% |